Kinesin-5 proteins are essential for formation of a bipolar mitotic spindle in most, and perhaps all, eukaryotic cells. Several Kinesin-5 proteins, notably the human version, HsEg5, are targets of a constantly expanding group of small-molecule inhibitors, which hold promise both as tools to probe mechanochemical transduction and as anti-cancer agents. Although most such compounds are selective for HsEg5 and closely related Kinesin-5 proteins, some, such as NSC 622124, exhibit activity against at least one kinesin from outside the Kinesin-5 family. Here we show NSC 622124, despite identification in a screen that yielded inhibitors now known to target the HsEg5 monastrol-binding site, does not compete with 14C-monastrol for binding to HsEg5, and is able to inhibit the basal and microtubule-stimulated ATPase activity of the monastrol-insensitive Kinesin-5, KLP61F. NSC 622124 competes with microtubules, but not ATP, for interaction with HsEg5, and disrupts the microtubule binding of HsEg5, KLP61F and Kinesin-1. Proteolytic degradation of an HsEg5•NSC622124 complex revealed that segments of the α3 and α5 helices map to the inhibitor-binding site. Overall, our results demonstrate that NSC 622124 targets the conserved microtubule-binding site of kinesin proteins. Further, unlike compounds previously reported to target the kinesin microtubule-binding site, NSC 622124 does not produce any enhancement of basal ATPase activity, and thus acts solely as a negative regulator through interaction with a site traditionally viewed as a binding region for positive regulators (i.e., microtubules). Our work emphasizes the concept that microtubule-dependent motor proteins may be controlled at multiple sites by both positive and negative effectors.
Kinesin‐5 proteins are essential for formation of a bipolar mitotic spindle in eukaryotic cells. Notably, the human Kinesin‐5 motor, HsEg5, is a target for an expanding group of small‐molecule inhibitors that hold promise both as tools to probe mechanochemical transduction and as anti‐cancer agents. Although most such compounds are selective for HsEg5, some exhibit activity against at least one kinesin from outside the Kinesin‐5 subfamily. Here we show NSC 622124, despite identification in an inhibitor screen targeting the HsEg5 monastrol‐binding site, does not compete with 14C‐monastrol for binding to HsEg5, and inhibits the basal and microtubule (MT)‐stimulated ATPase activity of the monastrol‐insensitive KLP61F. NSC 622124 competes with MTs, but not ATP, for interaction with HsEg5, and disrupts MT binding of other kinesins as well. Proteolytic degradation of an HsEg5▸NSC622124 complex revealed that segments of the α3 and α5 helices map to the inhibitor‐binding site. Overall, our results demonstrate that NSC 622124 targets the conserved MT‐binding site of kinesins. Further, NSC 622124 does not produce any enhancement of basal ATPase activity, and only acts as a negative regulator through interaction with a site traditionally viewed as a binding region for positive regulators. Our work emphasizes that MT‐dependent motor proteins may be controlled at multiple sites by both positive and negative effectors.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.